Richmond, Greater London – 24 February 2026: RX today announced the appointment of Alison Powell as its first Global Chief Marketing Officer (CMO). This newly created executive role underscores RX’s commitment to strengthening its global marketing capabilities to drive growth, customer value, and long-term enterprise performance.

Alison brings more than two decades of senior global marketing leadership experience across world‑class organisations including Elsevier, BP, AstraZeneca, and Kellogg’s, spanning both B2B and B2C environments. She joins RX from Elsevier Health, where she currently serves as Chief Marketing Officer, leading a global organisation of more than 190 marketers across international markets.

During her tenure at Elsevier Health, Alison led a major global marketing transformation, building a centralised, high-performing function with a strong commercial and governance focus. She embedded marketing ROI, performance visibility, and data‑driven decision-making, achieving measurable financial impact, sustained efficiency gains, and strong engagement results. She also championed AI-powered and digital innovation to enhance customer experience and scale.

In her new role at RX, Alison will be responsible for shaping and executing the company’s global marketing strategy, building scaled digital, data, and AI-enabled marketing capabilities, and leading a unified global marketing culture focused on excellence and results. All Business Unit Hub marketing leaders will report to her. Alison will report directly to Hugh Jones, Chief Executive Officer, and will join the Executive Leadership Team.

Commenting on the appointment, Hugh Jones, Chief Executive Officer, said: “I am delighted to welcome Alison to RX. Her deep global experience, her proven track record of driving transformational marketing performance, and her passion for customer-focused innovation make her the ideal leader to help accelerate our growth. Alison brings exactly the capabilities we need as we strengthen our marketing foundations and build for the future.” 

“I’m thrilled to be joining RX at such a pivotal moment. The company’s focus on innovation, customer value, and operational excellence is truly inspiring, and I look forward to working with colleagues around the world to elevate our marketing impact and help unlock the next chapter of growth for RX’s brands, exhibitors, and visitors,” said Alison Powell, Global Chief Marketing Officer.

ENDS

(1) Alison Jarvis-Powell | LinkedIn

About RX

RX is a global leader in events and exhibitions, leveraging industry expertise, data, and technology to build businesses for individuals, communities, and organisations. With a presence in 25 countries across 41 industry sectors, RX hosts approximately 350 events annually. RX is committed to creating an inclusive work environment for all our people. RX empowers businesses to thrive by leveraging data-driven insights and digital solutions. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.rxglobal.com.

About RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers. RELX serves customers in more than 180 countries and territories and has offices in about 40 countries. It employs more than 37,000 people, around 40% of whom are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.

*Note: Current market capitalisation can be found at http://www.relx.com/investors